ELARA’s mission is to provide novel and efficacious
medicines for the treatment of cancers with high 
unmet medical need. Seed capital was invested by 
EMBL Ventures and intellectual property licensed 
via EMBL Enterprise Management (EMBLEM)
(http://www.elarapharma.com)